T1	Participants 553 580	Belgium and The Netherlands
T2	Participants 593 656	406 previously untreated CHC patients, including 98 (24%) IVDUs
T3	Participants 46 101	chronic hepatitis C resulting from intravenous drug use
T4	Participants 1766 1789	Benelux patients, IVDUs
T5	Participants 1886 1919	other patients with CHC infection
T6	Participants 1985 2039	chronic hepatitis C patients who use intravenous drugs
